Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] (2019)
- Authors:
- Sousa, Juliana Cordeiro
- Ito, Mayumi Nóbrega
- Costa, Marilia Braga
- Farias, Izabelle Rocha
- Borges, Daniela Paula
- Oliveira, Roberta Taiane
- Fukutani, Kiyoshi Ferreira
- Thomé, Carolina Hassibe
- Martinelli, Camila Maria Silva
- Myajima, Fabio
- Vidal, Daniel Onofre
- Magalhães, Silvia Maria Meira
- Pontes, Lorena Lobo de Figueiredo
- Pinheiro, Ronald Feitosa
- USP affiliated authors: PONTES, LORENA LÔBO DE FIGUEIREDO - FMRP ; FUKUTANI, KIYOSHI FERREIRA - FMRP
- Unidade: FMRP
- DOI: 10.1002/hon.2608
- Subjects: HEMATOLOGIA; CÉLULAS DA MEDULA ÓSSEA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematological Oncology
- ISSN: 0278-0232
- Volume/Número/Paginação/Ano: v. 37, n. 4, p. 523-526, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SOUSA, Juliana Cordeiro et al. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hon.2608. Acesso em: 12 fev. 2026. , 2019 -
APA
Sousa, J. C., Ito, M. N., Costa, M. B., Farias, I. R., Borges, D. P., Oliveira, R. T., et al. (2019). Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/hon.2608 -
NLM
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1002/hon.2608 -
Vancouver
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1002/hon.2608 - Modulação da via de sinalização do TGFß e do VEGF pela oncoproteína PML-RARa
- Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation. [Carta]
- Chronic inflammation deters natural killer cell fitness and cytotoxicity in myeloid leukemia
- Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma
- Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
- Síndrome de diferenciação concomitante à infecção por COVID-19 em paciente com leucemia promielocítica aguda
- Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia
- Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
- Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]
- Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution
Informações sobre o DOI: 10.1002/hon.2608 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003009079.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
